Economic impact of delays in listing decisions by provincial drug plans after a positive Common Drug Review recommendation: the case of a smoking-cessation treatment. [electronic resource]
Producer: 20121026Description: 52-60 p. digitalISSN:- 1929-6347
- Adolescent
- Adult
- Age Factors
- Aged
- Benzazepines -- economics
- Cost-Benefit Analysis
- Drug Costs -- statistics & numerical data
- Female
- Humans
- Insurance, Health, Reimbursement -- economics
- Insurance, Pharmaceutical Services -- economics
- Male
- Middle Aged
- Quinoxalines -- economics
- Saskatchewan -- epidemiology
- Sex Factors
- Smoking -- drug therapy
- Smoking Cessation -- economics
- Time Factors
- Tobacco Use Cessation Devices -- economics
- Varenicline
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.